Updates

Craneware

November 2011

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

With the USA's widening budget deficit rivalling the Euro debt crisis for headlines, it's not surprising that Craneware, which supplies billing and auditing software to help US hospitals improve their financial performance, produced another strong performance in its year to June 2011. On revenues that rose 34% to US$38.1m, pretax profit increased 27% to US$9.3m while eps rose 17% to 25.6 cents. Year-end net cash was US$24.2m. Factors such as increased levels of fines for non compliance levied by Government regulators have increased the penetration of Craneware's products and it now counts more than 1,500 hospitals as clients. Growth has also come thanks to the launch of four new products and the maximum US$20m acquisition of Claim ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

ITE - Outlook still very stong

Tarsus - French disposal looks smart

Craneware (September 2013)

Craneware (November 2012)

Craneware - Second downgrade this year (August 2012)

Craneware (March 2012)

Craneware - New contract wins (September 2011)

Craneware - Acquistion raises forecasts (April 2011)

Craneware - Another amazing share price spike (December 2010)

Craneware - Shares spike vertically by over Â£1 (October 2010)

Craneware (June 2010)

Craneware - Billing software firm enjoying quick-fire growth (February 2010)

Craneware - Billing software firm sees huge US healthcare opportunity (October 2008)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X